e-learning
resources
Munich 2014
Monday, 08.09.2014
Latest insights in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: High-efficacy transduction of tyrosine-mutant adeno-associated virus serotype 8 vector in pulmonary gene therapy.
S. Martini, A. Silva, D. Ferreira, K. Gomes, F. Ornellas, M. Pacheco, H. Petrs-Silva, P. Rocco, M. Morales (Rio de Janeiro, Brazil)
Source:
International Congress 2014 – Latest insights in airway diseases
Session:
Latest insights in airway diseases
Session type:
Thematic Poster Session
Number:
2820
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Martini, A. Silva, D. Ferreira, K. Gomes, F. Ornellas, M. Pacheco, H. Petrs-Silva, P. Rocco, M. Morales (Rio de Janeiro, Brazil). LATE-BREAKING ABSTRACT: High-efficacy transduction of tyrosine-mutant adeno-associated virus serotype 8 vector in pulmonary gene therapy.. Eur Respir J 2014; 44: Suppl. 58, 2820
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Incorrect inhaler technique is common in patients with COPD – Data from the TIE study
A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroids
Related content which might interest you:
LATE-BREAKING ABSTRACT: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection.
Source: International Congress 2014 – COPD exacerbations
Year: 2014
LATE-BREAKING ABSTRACT: The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV)
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
LATE-BREAKING ABSTRACT: Inhibition of RC kinase is a novel therapeutic approach for the treatment of COPD and IPF
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Neuronal toll-like receptor (TLR) 7 expression and function in human airways
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Decametoxine efficiency in the treatment of infectious exacerbation of asthma
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016
IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
LATE-BREAKING ABSTRACT: Discovering new treatments for asthma and COPD. The use of the human viral challenge model with a newly manufactured and characterised GMP human rhinovirus
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
LATE-BREAKING ABSTRACT: Attenuation of allergen-induced asthmatic responses by inhaled GATA-3 specific DNAzyme
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Comparative lentiviral versus adenoviral gene transfer of GM-CSF to bone marrow-derived versus pulmonary macrophages of mice
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
In vivo effects of corticosteroid plus long-acting beta2-agonist on the expression of B7-H1/PD-L1 in double-stranded RNA-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Induction of galectin-9 production by viral infection in the lung
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Adeno-associated virus serotype 5 efficiently transduces human respiratory epithelium
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001
Modulation of PD-1 and PD-L1 expression in response to acute viral infection of human lung tissue
Source: International Congress 2014 – Cell biology 2014
Year: 2014
LATE-BREAKING ABSTRACT: A phase 2a study of benralizumab in adults with COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept